Literature DB >> 11259364

Regulation of Smad signaling by protein kinase C.

I Yakymovych1, P Ten Dijke, C H Heldin, S Souchelnytskyi.   

Abstract

Cross talk between transforming growth factor b(TGF-b) serine/threonine kinase receptor signaling and tyrosine kinase receptor signaling modulates cell responsiveness to polypeptide growth factors regulating cell proliferation, differentiation, and apoptosis. Here we provide a mechanism through which Smad-dependent TGF-b signaling is modulated by protein kinase C (PKC). PKC, for example, is activated downstream of tyrosine kinase receptors. We show that PKC directly phosphorylates receptor-regulated Smad proteins. This phosphorylation abrogates the ability of Smad3 to bind directly to DNA, which leads to subsequent inability to mediate transcriptional responses dependent on the direct binding of Smad3 to DNA. Interference with PKC regulation of Smad functions increased cell sensitivity to transformation by the tumor promoter phorbol 12-myristate 13-acetate (PMA). PKC-dependent phosphorylation of Smad3 was found also to be a key event in the PMA-dependent inactivation of TGF-b-stimulated cell death. Thus, PKC-dependent phosphorylation of Smad3 leads to down-regulation of the growth inhibitory and apoptotic action of TGF-b.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259364     DOI: 10.1096/fj.00-0474fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  37 in total

1.  Functional proteomics of transforming growth factor-beta1-stimulated Mv1Lu epithelial cells: Rad51 as a target of TGFbeta1-dependent regulation of DNA repair.

Authors:  Takashi Kanamoto; Ulf Hellman; Carl-Henrik Heldin; Serhiy Souchelnytskyi
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

2.  Time-varying causal inference from phosphoproteomic measurements in macrophage cells.

Authors:  Maryam Masnadi-Shirazi; Mano Ram Maurya; Shankar Subramaniam
Journal:  IEEE Trans Biomed Circuits Syst       Date:  2014-02       Impact factor: 3.833

3.  MicroRNA-204/211 alters epithelial physiology.

Authors:  Fei E Wang; Connie Zhang; Arvydas Maminishkis; Lijin Dong; Connie Zhi; Rong Li; Jing Zhao; Vladimir Majerciak; Arti B Gaur; Shan Chen; Sheldon S Miller
Journal:  FASEB J       Date:  2010-01-07       Impact factor: 5.191

4.  Regulation of TGF-β signaling by PKC depends on Tsc-22 inducibility.

Authors:  Hyesun Ahn; Taehee Han
Journal:  Mol Cell Biochem       Date:  2011-09-01       Impact factor: 3.396

Review 5.  Connective tissue disorders and cardiovascular complications: the indomitable role of transforming growth factor-beta signaling.

Authors:  Jason B Wheeler; John S Ikonomidis; Jeffrey A Jones
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 6.  To (TGF)beta or not to (TGF)beta: fine-tuning of Smad signaling via post-translational modifications.

Authors:  Katharine H Wrighton; Xin-Hua Feng
Journal:  Cell Signal       Date:  2008-02-15       Impact factor: 4.315

7.  TGF-beta1 attenuates mediator release and de novo Kit expression by human skin mast cells through a Smad-dependent pathway.

Authors:  Wei Zhao; Gregorio Gomez; Shao-Hua Yu; John J Ryan; Lawrence B Schwartz
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

8.  Identification of crosstalk between phosphoprotein signaling pathways in RAW 264.7 macrophage cells.

Authors:  Shakti Gupta; Mano Ram Maurya; Shankar Subramaniam
Journal:  PLoS Comput Biol       Date:  2010-01-29       Impact factor: 4.475

Review 9.  Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis.

Authors:  Jeffrey A Jones; Francis G Spinale; John S Ikonomidis
Journal:  J Vasc Res       Date:  2008-09-02       Impact factor: 1.934

10.  BRCA1 interacts with Smad3 and regulates Smad3-mediated TGF-beta signaling during oxidative stress responses.

Authors:  Huchun Li; Masayuki Sekine; Seyha Seng; Shalom Avraham; Hava Karsenty Avraham
Journal:  PLoS One       Date:  2009-09-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.